Monitoring of trough plasma ganciclovir levels and peripheral blood cytomegalovirus (CMV)-specific CD8+ T cells to predict CMV DNAemia clearance in preemptively treated allogeneic stem cell transplant recipients. [electronic resource]
Producer: 20150915Description: 5602-5 p. digitalISSN:- 1098-6596
- Adult
- Anemia, Aplastic -- surgery
- CD8-Positive T-Lymphocytes -- immunology
- Cytomegalovirus -- drug effects
- Cytomegalovirus Infections -- drug therapy
- DNA, Viral -- blood
- Female
- Ganciclovir -- analogs & derivatives
- Humans
- Interferon-gamma -- blood
- Leukemia, Myeloid, Acute -- surgery
- Lymphoma, Non-Hodgkin -- surgery
- Male
- Middle Aged
- Multiple Myeloma -- surgery
- Phosphoproteins -- blood
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- surgery
- Stem Cell Transplantation
- Transplant Recipients
- Valganciclovir
- Viral Matrix Proteins -- blood
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.